Shopping Cart
- Remove All
- Your shopping cart is currently empty
SCO-267 is a potent allosteric full agonist of the GPR40 receptor, making it a valuable tool in studying chronic diseases like diabetes.
Description | SCO-267 is a potent allosteric full agonist of the GPR40 receptor, making it a valuable tool in studying chronic diseases like diabetes. |
In vitro | SCO-267, when applied to CHO cells, stimulates the Gαq, Gαs, and Gα12/13 pathways alongside β-Arrestin recruitment. It functions as an allosteric partner to fasiglifam and interacts with an endogenous ligand[1]. |
In vivo | SCO-267, administered orally at doses of 1 or 10 mg/kg, enhances insulin sensitivity and demonstrates a prolonged effect in reducing glucose levels. This was observed in a study using N-STZ rat models, confirming the compound's efficacy in modulating glucose metabolism at specified dosages. |
Molecular Weight | 614.787 |
Formula | C36H46N4O5 |
Cas No. | 1656261-09-4 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.